Cargando…
Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262637/ https://www.ncbi.nlm.nih.gov/pubmed/34250480 http://dx.doi.org/10.1093/noajnl/vdab045 |
| _version_ | 1783719223419207680 |
|---|---|
| author | McCord, Matthew Lukas, Rimas V Amidei, Christina Demars, Nathan Gelb, Arnold Buck, Jill Sachdev, Sean Feldman, Alexander Tate, Matthew Dixit, Karan Brat, Daniel J Jennings, Lawrence Horbinski, Craig |
| author_facet | McCord, Matthew Lukas, Rimas V Amidei, Christina Demars, Nathan Gelb, Arnold Buck, Jill Sachdev, Sean Feldman, Alexander Tate, Matthew Dixit, Karan Brat, Daniel J Jennings, Lawrence Horbinski, Craig |
| author_sort | McCord, Matthew |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8262637 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82626372021-07-08 Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient McCord, Matthew Lukas, Rimas V Amidei, Christina Demars, Nathan Gelb, Arnold Buck, Jill Sachdev, Sean Feldman, Alexander Tate, Matthew Dixit, Karan Brat, Daniel J Jennings, Lawrence Horbinski, Craig Neurooncol Adv Molecular Tumor Board Case Report Oxford University Press 2021-03-15 /pmc/articles/PMC8262637/ /pubmed/34250480 http://dx.doi.org/10.1093/noajnl/vdab045 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Molecular Tumor Board Case Report McCord, Matthew Lukas, Rimas V Amidei, Christina Demars, Nathan Gelb, Arnold Buck, Jill Sachdev, Sean Feldman, Alexander Tate, Matthew Dixit, Karan Brat, Daniel J Jennings, Lawrence Horbinski, Craig Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient |
| title | Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient |
| title_full | Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient |
| title_fullStr | Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient |
| title_full_unstemmed | Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient |
| title_short | Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient |
| title_sort | disappearance of mmr-deficient subclones after controlled il-12 and pd-1 inhibition in a glioma patient |
| topic | Molecular Tumor Board Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262637/ https://www.ncbi.nlm.nih.gov/pubmed/34250480 http://dx.doi.org/10.1093/noajnl/vdab045 |
| work_keys_str_mv | AT mccordmatthew disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT lukasrimasv disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT amideichristina disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT demarsnathan disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT gelbarnold disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT buckjill disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT sachdevsean disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT feldmanalexander disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT tatematthew disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT dixitkaran disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT bratdanielj disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT jenningslawrence disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient AT horbinskicraig disappearanceofmmrdeficientsubclonesaftercontrolledil12andpd1inhibitioninagliomapatient |